Company profile
Baseimmune
Baseimmune data-driven vaccine design
Financial period: 1 Nov 2023 to 31 Oct 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
AA01 | Transaction MzQ0MzA2MDE4NGFkaXF6a2N4
Published 13 Nov 2024 01:24
CS01 | Transaction MzQ0MjA2MDgyNGFkaXF6a2N4
Published 05 Nov 2024 03:28
RP04SH01 | Transaction MzQ0MTYwNjk4MGFkaXF6a2N4 | Paper/PDF filed
Published 05 Nov 2024 07:28
Last accounts made up date
Company registered at Companies House
1 Dec 2023 to 31 Mar 2026
The rapid development, manufacture and supply of mRNA vaccines against COVID-19 is one of the greatest success stories in modern medicine. Demonstrably safe and effective in over billion patients, the question now is not if, but how quickly, this revolutionary combination of an mRNA therapy and lipid nanoparticle (LNP) carrier can be expanded to and explo...
